LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

13-03-2019

LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

Vchal / Shutterstock.com

Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.


HGF, Claire Irvine, CRISPR, DNA, technology, gene-editing, CRISPIR/Cas9, patent, University of California, Broad Institute, webinar

LSIPR